CHARLES RIVER LABORATORIES INTERNATIONAL, INC. acquires Primedica Corporation

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. acquired Primedica Corporation for ~$51.9M, a transaction completed in February 2001, structured as Cash, restricted stock and assumed liabilities; purchased from Genzyme Transgenics Corporation.

Primedica Corporation operates in Discovery and Safety Assessment (DSA), is based in United States (Worcester, Massachusetts). Charles River acquired Primedica Corporation from Genzyme Transgenics Corporation. Headquartered in Worcester, Massachusetts, Primedica was a leading provider of preclinical drug discovery and development services to the biopharmaceutical industry, broadening Charles River's outsourced development-services offering.

Expand Charles River's preclinical drug discovery and development service capabilities for biopharmaceutical clients.

Advisory firms were not disclosed for this transaction.

You're subscribed.

Thanks for signing up.